Derek M. Meisner, Chief Legal Officer & Corporate Secretary at Acumen Pharmaceuticals, Inc. (ABOS), sold 101,318 shares at $1.82 ($182K) on 2026-01-08, disclosed to the SEC on 2026-01-12.
Seasonal sale ($182k) by Chief Legal Officer & Corporate Secretary — this insider has traded ABOS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.82 | 6,819 | $12K | 6.8% |
| 2 | $1.82 | 6,819 | $12K | 6.8% |
| 3 | $1.82 | 30,092 | $55K | 30.1% |
| 4 | $1.82 | 30,092 | $55K | 30.1% |
| 5 | $1.76 | 5,200 | $9K | 5.0% |
| 6 | $1.76 | 5,200 |
| $9K |
| 5.0% |
| 7 | $1.71 | 8,548 | $15K | 8.0% |
| 8 | $1.71 | 8,548 | $15K | 8.1% |
| Total | $1.80 avg | 101,318 | $182K | 100% |
| Filing → |
| ABOS | SELL | 2026-01-28 | $107K | — | Filing → |
| ABOS | SELL | 2026-01-23 | $31K | — | Filing → |
| ABOS | SELL | 2026-01-07 | $53K | — | Filing → |